Drug Patent Portfolio Management: The Complete Playbook for Protecting Billions in Pharma IP
Every blockbuster drug is, at its core, a time-limited monopoly. The moment that monopoly expires, the revenue collapses. Pfizer watched […]
$445 Billion Saved, 13% of Spend: The Complete Analyst’s Guide to Generic Drug Economics, IP Strategy, and Market Power
The U.S. generic drug market saved the healthcare system $445 billion in 2023 alone. Generics fill 90% of all prescriptions
Generic Drug Risk Management Plans: The Complete RMP & REMS Playbook
1. Why Risk Management Now Determines Competitive Position Generic drugs fill 91% of all prescriptions dispensed in the United States
Generic Drug Risk Management Plans: The Complete RMP & REMS Playbook Read Post »
Generic Drug Economics: The Complete Market, IP, and Policy Playbook
Generic drugs account for approximately 90% of all prescriptions dispensed in the United States, yet they represent only about 18%
Generic Drug Economics: The Complete Market, IP, and Policy Playbook Read Post »
Unlocking the Potential of Abandoned and Expired Patents: A Strategic Guide to Competitive Advantage
Drug patent abandonment is not a clerical failure. It is a calculated move within a broader lifecycle management strategy or
The CDMO Strategic Intelligence Playbook: 10 High-Value Services That Separate Winning Drug Programs from the Rest
The contract development and manufacturing organization industry crossed $238 billion in global market value in 2024. By 2032, analysts project
The Persistent Problem: Why Hospitals Keep Running Out of Generic Drugs
The U.S. generic drug market saves $445 billion a year. It also fails, systematically and predictably, to keep the most
The Persistent Problem: Why Hospitals Keep Running Out of Generic Drugs Read Post »
Generic Drug Regulatory Strategy: The Complete Playbook for Pharma IP Teams
1. What a Generic Drug Actually Is, Legally and Commercially The Regulatory Definition and Why It Is a Legal Construct,
Generic Drug Regulatory Strategy: The Complete Playbook for Pharma IP Teams Read Post »
Why Google Patents Fails Drug Patent Searches — And What to Use Instead
A field-by-field breakdown of 15 structural flaws that put pharmaceutical IP strategy at risk There is a particular kind of
Why Google Patents Fails Drug Patent Searches — And What to Use Instead Read Post »
